Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea
Authors:
- Eui-Soon KimEKEui-Soon Kim
- Sun-Kyeong ParkSPSun-Kyeong Park
- Jong-Chan YounJYJong-Chan Youn
- Hye Sun LeeHLHye Sun Lee
- Hae-Young LeeHLHae-Young Lee
- Hyun-Jai ChoHCHyun-Jai Cho
- Jin-Oh ChoiJCJin-Oh Choi
- Eun-Seok JeonEJEun-Seok Jeon
- Sang Eun LeeSLSang Eun Lee
- Min-Seok KimMKMin-Seok Kim
- Jae-Joong KimJKJae-Joong Kim
- Kyung-Kuk HwangKHKyung-Kuk Hwang
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (1) , e8
Abstract
Kim ES, et al. J Korean Med Sci. 2023 Dec;39(1):e8. https://doi.org/10.3346/jkms.2024.39.e8Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1F1A1063430)
- Korea Centers for Disease Control and Prevention (2010-E63003-00, 2011-E63002-00, 2012-E63005-00, 2013-E6300300, 2014-E63003-01, 2015-E63003-02, 2016-ER6303-00, 2017-ER6303-01)
This publication has 32 references indexed in Scilit:
- Eligibility of Sacubitril–Valsartan in a Real-World Heart Failure Population: A Community-Based Single-Centre StudyESC Heart Failure, 2018
- Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice projectEuropean Journal of Preventive Cardiology, 2017
- Temporal Trends of Hospitalized Patients with Heart Failure in KoreaKorean Circulation Journal, 2017
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- A Multicentre Cohort Study of Acute Heart Failure Syndromes in Korea: Rationale, Design, and Interim Observations of the Korean Acute Heart Failure (KorAHF) RegistryEuropean Journal of Heart Failure, 2014
- The association between blood pressure and mortality in patients with heart failureAmerican Heart Journal, 2006
- Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation StudyNew England Journal of Medicine, 2004
- Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failureAmerican Heart Journal, 2003
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001
- The Progression From Hypertension to Congestive Heart FailureJAMA, 1996